Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 23 | 2024 | 9747 | 2.330 |
Why?
|
| Recovery of Function | 15 | 2023 | 2965 | 1.930 |
Why?
|
| Motor Cortex | 2 | 2023 | 1003 | 0.880 |
Why?
|
| Multiple System Atrophy | 2 | 2016 | 132 | 0.880 |
Why?
|
| Upper Extremity | 11 | 2023 | 682 | 0.860 |
Why?
|
| Paresis | 3 | 2023 | 176 | 0.730 |
Why?
|
| Dysarthria | 1 | 2020 | 57 | 0.700 |
Why?
|
| Consciousness Disorders | 1 | 2023 | 445 | 0.620 |
Why?
|
| Pyramidal Tracts | 2 | 2019 | 249 | 0.610 |
Why?
|
| Encephalomyelitis | 1 | 2018 | 37 | 0.600 |
Why?
|
| Pneumonia, Mycoplasma | 1 | 2018 | 50 | 0.590 |
Why?
|
| Consciousness | 1 | 2023 | 601 | 0.580 |
Why?
|
| Diplopia | 1 | 2018 | 217 | 0.540 |
Why?
|
| Occupational Therapy | 2 | 2023 | 140 | 0.510 |
Why?
|
| Nerve Regeneration | 1 | 2020 | 800 | 0.440 |
Why?
|
| Neurology | 2 | 2018 | 784 | 0.430 |
Why?
|
| Central Nervous System Fungal Infections | 1 | 2013 | 23 | 0.430 |
Why?
|
| Geniculate Bodies | 1 | 2014 | 157 | 0.410 |
Why?
|
| Psychomotor Performance | 1 | 2021 | 1883 | 0.410 |
Why?
|
| Nervous System Diseases | 1 | 2023 | 1659 | 0.400 |
Why?
|
| Long-Term Potentiation | 1 | 2014 | 290 | 0.400 |
Why?
|
| Career Choice | 1 | 2018 | 769 | 0.390 |
Why?
|
| Aphasia | 1 | 2023 | 191 | 0.360 |
Why?
|
| Fever | 1 | 2018 | 1602 | 0.350 |
Why?
|
| Candidiasis | 1 | 2013 | 371 | 0.350 |
Why?
|
| Faculty, Medical | 1 | 2018 | 1219 | 0.340 |
Why?
|
| Visual Pathways | 1 | 2014 | 555 | 0.330 |
Why?
|
| Photorefractive Keratectomy | 1 | 2008 | 34 | 0.290 |
Why?
|
| Corneal Topography | 1 | 2008 | 69 | 0.290 |
Why?
|
| Lasers, Excimer | 1 | 2008 | 68 | 0.290 |
Why?
|
| alpha-Synuclein | 1 | 2014 | 772 | 0.280 |
Why?
|
| Keratomileusis, Laser In Situ | 1 | 2008 | 81 | 0.270 |
Why?
|
| Cerebellum | 1 | 2014 | 1519 | 0.260 |
Why?
|
| Keratoconus | 1 | 2008 | 112 | 0.260 |
Why?
|
| Activities of Daily Living | 6 | 2023 | 2415 | 0.260 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2019 | 2805 | 0.260 |
Why?
|
| Synapses | 1 | 2014 | 1754 | 0.230 |
Why?
|
| Robotics | 2 | 2023 | 808 | 0.230 |
Why?
|
| Brain Diseases | 1 | 2013 | 1550 | 0.220 |
Why?
|
| Amantadine | 1 | 2023 | 58 | 0.220 |
Why?
|
| Humans | 41 | 2024 | 765734 | 0.200 |
Why?
|
| Academic Medical Centers | 2 | 2018 | 2779 | 0.200 |
Why?
|
| Brain | 5 | 2024 | 27178 | 0.180 |
Why?
|
| Transcranial Magnetic Stimulation | 3 | 2021 | 1496 | 0.180 |
Why?
|
| Movement | 2 | 2022 | 1461 | 0.170 |
Why?
|
| Occupational Health | 1 | 2006 | 813 | 0.170 |
Why?
|
| Neurosurgical Procedures | 2 | 2021 | 2081 | 0.160 |
Why?
|
| Carbidopa | 1 | 2018 | 30 | 0.160 |
Why?
|
| Epoetin Alfa | 1 | 2018 | 78 | 0.160 |
Why?
|
| Speech Therapy | 1 | 2018 | 58 | 0.150 |
Why?
|
| Levodopa | 1 | 2018 | 221 | 0.150 |
Why?
|
| Gait | 1 | 2023 | 820 | 0.140 |
Why?
|
| Spinocerebellar Degenerations | 1 | 2016 | 44 | 0.140 |
Why?
|
| Chorionic Gonadotropin | 1 | 2018 | 457 | 0.130 |
Why?
|
| Dopamine Agonists | 1 | 2018 | 346 | 0.130 |
Why?
|
| Walking | 1 | 2023 | 1198 | 0.120 |
Why?
|
| Limbic Encephalitis | 1 | 2015 | 36 | 0.120 |
Why?
|
| Fluoxetine | 1 | 2019 | 730 | 0.120 |
Why?
|
| Vagus Nerve Stimulation | 1 | 2018 | 228 | 0.120 |
Why?
|
| Physical Therapy Modalities | 1 | 2018 | 533 | 0.120 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2020 | 1168 | 0.120 |
Why?
|
| Smoking Cessation | 1 | 2006 | 2084 | 0.110 |
Why?
|
| Stem Cells | 1 | 2007 | 3539 | 0.110 |
Why?
|
| Disabled Persons | 1 | 2024 | 1208 | 0.110 |
Why?
|
| Neurodegenerative Diseases | 1 | 2023 | 1087 | 0.110 |
Why?
|
| Research Personnel | 1 | 2018 | 590 | 0.110 |
Why?
|
| Continuity of Patient Care | 1 | 2021 | 1078 | 0.110 |
Why?
|
| Neurologic Examination | 1 | 2016 | 913 | 0.110 |
Why?
|
| Neurogenesis | 1 | 2020 | 865 | 0.110 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2014 | 366 | 0.100 |
Why?
|
| Cerebellar Ataxia | 1 | 2014 | 150 | 0.100 |
Why?
|
| Acute Disease | 1 | 2023 | 7232 | 0.100 |
Why?
|
| Drug Combinations | 1 | 2018 | 2075 | 0.100 |
Why?
|
| Attitude of Health Personnel | 1 | 2006 | 3926 | 0.100 |
Why?
|
| Glioma | 1 | 2007 | 3493 | 0.100 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2023 | 1483 | 0.100 |
Why?
|
| Female | 12 | 2024 | 395961 | 0.100 |
Why?
|
| Male | 10 | 2024 | 363585 | 0.090 |
Why?
|
| Neuromyelitis Optica | 1 | 2015 | 266 | 0.090 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2006 | 4057 | 0.090 |
Why?
|
| Adult | 9 | 2024 | 222974 | 0.090 |
Why?
|
| Parkinsonian Disorders | 1 | 2014 | 286 | 0.090 |
Why?
|
| Fibrinolytic Agents | 1 | 2020 | 2081 | 0.090 |
Why?
|
| Brain Stem | 1 | 2015 | 854 | 0.090 |
Why?
|
| Burnout, Professional | 1 | 2018 | 710 | 0.080 |
Why?
|
| Linear Models | 1 | 2019 | 5876 | 0.080 |
Why?
|
| Age of Onset | 1 | 2016 | 3339 | 0.080 |
Why?
|
| Smoking | 1 | 2006 | 9077 | 0.080 |
Why?
|
| Interneurons | 1 | 2014 | 593 | 0.080 |
Why?
|
| Motor Activity | 1 | 2019 | 2705 | 0.080 |
Why?
|
| Aged | 5 | 2024 | 171050 | 0.080 |
Why?
|
| Arm | 2 | 2023 | 588 | 0.080 |
Why?
|
| Chronic Disease | 1 | 2023 | 9351 | 0.080 |
Why?
|
| Middle Aged | 6 | 2024 | 222903 | 0.080 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 14745 | 0.070 |
Why?
|
| Retinal Ganglion Cells | 1 | 2014 | 810 | 0.070 |
Why?
|
| Electroencephalography | 1 | 2023 | 6275 | 0.070 |
Why?
|
| Neurons | 1 | 2007 | 9521 | 0.070 |
Why?
|
| Brain Ischemia | 1 | 2021 | 3000 | 0.070 |
Why?
|
| Refractive Errors | 1 | 2008 | 148 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 6499 | 0.060 |
Why?
|
| Brain Neoplasms | 1 | 2007 | 9071 | 0.060 |
Why?
|
| Auditory Perception | 1 | 2010 | 587 | 0.060 |
Why?
|
| Logistic Models | 1 | 2019 | 13261 | 0.060 |
Why?
|
| Bayes Theorem | 2 | 2023 | 2354 | 0.060 |
Why?
|
| Phenotype | 1 | 2022 | 16706 | 0.060 |
Why?
|
| Immunoglobulin G | 1 | 2015 | 4527 | 0.050 |
Why?
|
| Cognition | 1 | 2021 | 7048 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2024 | 36537 | 0.050 |
Why?
|
| Atlases as Topic | 1 | 2024 | 247 | 0.050 |
Why?
|
| Homeostasis | 1 | 2014 | 3336 | 0.050 |
Why?
|
| Prognosis | 1 | 2023 | 29899 | 0.050 |
Why?
|
| Social Behavior | 1 | 2009 | 1144 | 0.050 |
Why?
|
| California | 1 | 2006 | 1434 | 0.050 |
Why?
|
| Gene Transfer Techniques | 1 | 2007 | 1216 | 0.050 |
Why?
|
| Visual Perception | 1 | 2010 | 1394 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2007 | 2061 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 12949 | 0.050 |
Why?
|
| Microscopy, Confocal | 1 | 2007 | 1965 | 0.050 |
Why?
|
| Neurophysiology | 1 | 2021 | 145 | 0.040 |
Why?
|
| Choline | 1 | 2023 | 511 | 0.040 |
Why?
|
| Creatine | 1 | 2023 | 424 | 0.040 |
Why?
|
| Young Adult | 2 | 2018 | 59852 | 0.040 |
Why?
|
| Aspartic Acid | 1 | 2023 | 576 | 0.040 |
Why?
|
| Animals | 3 | 2020 | 168731 | 0.040 |
Why?
|
| Autistic Disorder | 1 | 2009 | 1239 | 0.040 |
Why?
|
| Disease Progression | 1 | 2016 | 13614 | 0.040 |
Why?
|
| Models, Neurological | 1 | 2007 | 1748 | 0.040 |
Why?
|
| Attention | 1 | 2009 | 2417 | 0.040 |
Why?
|
| Stem Cell Transplantation | 1 | 2007 | 1601 | 0.040 |
Why?
|
| Evoked Potentials, Motor | 1 | 2021 | 463 | 0.040 |
Why?
|
| Visual Acuity | 1 | 2008 | 2672 | 0.040 |
Why?
|
| Lactic Acid | 1 | 2023 | 1138 | 0.040 |
Why?
|
| Reoperation | 1 | 2008 | 4294 | 0.040 |
Why?
|
| Cross-Sectional Studies | 3 | 2023 | 26284 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2021 | 81457 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2023 | 1820 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 22321 | 0.030 |
Why?
|
| Acoustic Stimulation | 2 | 2010 | 1255 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 39180 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 18289 | 0.030 |
Why?
|
| Focus Groups | 1 | 2021 | 1459 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2010 | 8926 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2010 | 5768 | 0.030 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2024 | 2415 | 0.030 |
Why?
|
| Language | 1 | 2023 | 1549 | 0.030 |
Why?
|
| Neural Pathways | 1 | 2024 | 3087 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2016 | 54795 | 0.020 |
Why?
|
| Social Support | 1 | 2021 | 2193 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2021 | 5302 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 17062 | 0.020 |
Why?
|
| United States | 2 | 2023 | 72898 | 0.020 |
Why?
|
| Hippocampus | 1 | 2022 | 3774 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 21053 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2019 | 65180 | 0.020 |
Why?
|
| Fixation, Ocular | 1 | 2009 | 243 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 8528 | 0.020 |
Why?
|
| Mice | 1 | 2014 | 81792 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2015 | 2112 | 0.020 |
Why?
|
| Computers | 1 | 2009 | 588 | 0.020 |
Why?
|
| Calibration | 1 | 2009 | 814 | 0.020 |
Why?
|
| Algorithms | 1 | 2007 | 14061 | 0.020 |
Why?
|
| Speech | 1 | 2010 | 555 | 0.020 |
Why?
|
| Motion | 1 | 2009 | 781 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2019 | 12433 | 0.010 |
Why?
|
| Video Recording | 1 | 2009 | 970 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2021 | 5506 | 0.010 |
Why?
|
| Light | 1 | 2009 | 1364 | 0.010 |
Why?
|
| Photic Stimulation | 1 | 2009 | 1993 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2010 | 6203 | 0.010 |
Why?
|
| Quality of Life | 1 | 2022 | 13462 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2010 | 6598 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2009 | 42468 | 0.000 |
Why?
|
Concepts
(173)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(23)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_